Mathematical Models of the Complete Course of HIV Infection and AIDS
暂无分享,去创建一个
[1] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[2] D. Weissman,et al. Immunopathogenic mechanisms of HIV infection. , 1996, Annals of internal medicine.
[3] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[4] C. Fox,et al. Macrophages as a source of HIV during opportunistic infections. , 1997, Science.
[5] A. Haase,et al. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.
[6] Louis J. Picker,et al. Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.
[7] R. M. Zorzenon dos Santos,et al. Dynamics of HIV infection: a cellular automata approach. , 2001, Physical review letters.
[8] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[9] Daniel C. Douek,et al. Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection1 , 2001, The Journal of Immunology.
[10] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[11] M A Nowak,et al. Dynamics of macrophage and T cell infection by HIV. , 1999, Journal of theoretical biology.
[12] W Turner,et al. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. , 1998, The Journal of clinical investigation.
[13] D. Ho,et al. HIV-1 dynamics in vivo. , 1995, Journal of biological regulators and homeostatic agents.
[14] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[15] M. Hirsch,et al. Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.
[16] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[17] J. Mcdougal,et al. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). , 1986, Journal of immunology.
[18] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[19] Alan S. Perelson,et al. Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.
[20] M. Lederman,et al. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. , 1994, Journal of acquired immune deficiency syndromes.
[21] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] N Bischofberger,et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[24] J. Justement,et al. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Gendelman,et al. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. , 1991, Journal of immunology.
[26] M Kapadvanjwala,et al. A mathematical simulation of the AIDS patient and extracorporeal detoxification. , 1989, Computers in biology and medicine.
[27] F. Miedema,et al. In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro. , 1998, The Journal of infectious diseases.
[28] G. Eddy,et al. Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. , 1994, AIDS research and human retroviruses.
[29] A S Perelson,et al. Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.
[30] A. Perelson,et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.
[31] A. Merzouki,et al. T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide , 2000, Journal of Virology.
[32] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[33] Pei Yu,et al. Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy , 2001, Comput. Biol. Medicine.